AGL 39.50 Decreased By ▼ -0.50 (-1.25%)
AIRLINK 129.00 Decreased By ▼ -0.06 (-0.05%)
BOP 6.71 Decreased By ▼ -0.04 (-0.59%)
CNERGY 4.69 Increased By ▲ 0.20 (4.45%)
DCL 8.54 Decreased By ▼ -0.01 (-0.12%)
DFML 41.07 Increased By ▲ 0.25 (0.61%)
DGKC 81.40 Increased By ▲ 0.44 (0.54%)
FCCL 32.93 Increased By ▲ 0.16 (0.49%)
FFBL 74.79 Increased By ▲ 0.36 (0.48%)
FFL 11.87 Increased By ▲ 0.13 (1.11%)
HUBC 109.50 Decreased By ▼ -0.08 (-0.07%)
HUMNL 14.28 Increased By ▲ 0.53 (3.85%)
KEL 5.27 Decreased By ▼ -0.04 (-0.75%)
KOSM 7.60 Decreased By ▼ -0.12 (-1.55%)
MLCF 38.40 Decreased By ▼ -0.20 (-0.52%)
NBP 65.10 Increased By ▲ 1.59 (2.5%)
OGDC 192.75 Decreased By ▼ -1.94 (-1%)
PAEL 25.75 Increased By ▲ 0.04 (0.16%)
PIBTL 7.35 Decreased By ▼ -0.04 (-0.54%)
PPL 152.68 Decreased By ▼ -2.77 (-1.78%)
PRL 25.50 Decreased By ▼ -0.29 (-1.12%)
PTC 17.50 No Change ▼ 0.00 (0%)
SEARL 79.50 Increased By ▲ 0.85 (1.08%)
TELE 7.80 Decreased By ▼ -0.06 (-0.76%)
TOMCL 33.65 Decreased By ▼ -0.08 (-0.24%)
TPLP 8.54 Increased By ▲ 0.14 (1.67%)
TREET 16.15 Decreased By ▼ -0.12 (-0.74%)
TRG 58.00 Decreased By ▼ -0.22 (-0.38%)
UNITY 27.70 Increased By ▲ 0.21 (0.76%)
WTL 1.39 No Change ▼ 0.00 (0%)
BR100 10,531 Increased By 86.2 (0.83%)
BR30 31,106 Decreased By -83 (-0.27%)
KSE100 98,787 Increased By 989.1 (1.01%)
KSE30 30,838 Increased By 357.5 (1.17%)

The Special Assistant on Health Dr Zafar Mirza on Saturday announced that long-awaited National Medicine Policy will be announced by end of next month. Dr Zafar Mirza, while addressing a seminar in Rawalpindi, predicted that the pharmaceutical sector will witness revolutionary changes in the near future. The special assistant detailed that an outline on the constitution of the country's medicine policy had been prepared in a high-meeting which was attended by the representatives of pharmaceutical companies and other stakeholders from all four provinces.

Earlier in May, Dr Zafar Mirza had said that the government has decided to present a new national medicines policy to regulate the pharmaceutical industry and controlling the prices of the drug. The minister had said that the new policy is being made in consultation with all stakeholders to ensure availability of life-saving drugs and keeping prices of all drugs in reach of a layman, a state news agency reported on May 16.

He said that the new medicines policy will also cover the aspect of rules and regulations to streamline the production of medicines and maintaining its quality as per international standard. Dr Mirza said that under this policy, the government will also get inputs from the stakeholders for announcing more incentives for the pharma industry in order to convince those producing standard medicines in the market. He said that the new policy will also manage the issues related to the sale of medicines without prescription of medical practitioners and open sale of unauthorized medicines to customers.

He revealed plans that the government decided to make Drug Regulatory Authority of Pakistan (DRAP) a model regulatory authority with the introduction of new reforms in order to facilitate the people and addressing the issues of quality and pricing of drugs.

Copyright News Network International, 2019

Comments

Comments are closed.